Providing digital security of healthcare system with criminal-legal means

Objective: to develop a comprehensive system of ethical principles for the formation of a regulatory framework and the practical implementation of digital bioprinting technologies in clinical practice.

Methods: the research is based on the application of general scientific methods of scientific cognition (analysis, synthesis, induction, deduction, systematic approach), as well as private scientific methods of scientific cognition, including the logical and legal method.

Results: the ethical and legal issues of 3D (three-dimensional) bioprinting as a developing field of high-tech medical care have not yet been widely discussed among specialists dealing with bioethics issues. The field of 3D bioprinting includes not only advanced technologies for printing human tissues and organs, but also raises a whole range of interdisciplinary scientific issues. The digital transformation of the healthcare system will inevitably entail an improvement in the regulatory regulation of bioprinting technologies, however, given the certain stability of the law, this will take a significant amount of time.

Scientific novelty: a system of ethical principles has been developed that can form the basis of the law-making process of this digital technology and its practical implementation in clinical medicine. The ethical principles outlined by us in a systematic form can serve as the basis for the development and implementation of domestic legal regulation of bioprinting technologies. Based on the formulated ethical principles, it is possible to consider specific measures to improve domestic legislation and, in general, prevent potential negative consequences resulting from their application, which will allow technology to develop and will not be considered as an attempt by the state to establish control over it.

Practical significance: the research results, including theoretical provisions, practical recommendations and conclusions, can be effectively used to form a legal environment for bioprinting technologies, develop scientific research at the intersection of medicine, digital technologies and fundamental science, and improve the regulatory framework in the field of high-tech medical care.

1. Akhmadova, M. A. (2020). Some questions of legal regulation of bioprinting in Russia. Sociopolitical Sciences, 10(2), 196–204. (In Russ.). https://doi.org/10.33693/2223-0092-2020-10-2-196-204

2. Belikova, K. M. (2020). Bioprinting and culture of tissues and organs in the BRICS countries (on the example of Brazil, India, China, and South Africa): approaches of legislation on intellectual property. Law and Politics, 5, 35–57. (In Russ.). https://doi.org/10.7256/2454-0706.2020.5.32826

3. Berg, J., & Kurreck, J. (2021). Clean bioprinting - Fabrication of 3D organ models devoid of animal components. ALTEX, 38(2), 269–288. https://doi.org/10.14573/altex.2009151

4. Bogdanov, D. E. (2020b). Techno-Determinism in Private Law: Influence of Bioprinting on Developing the Concept of Protecting the Right to Digital Image. Perm University Herald. Juridical Sciences, 50, 678–704. (In Russ.). https://doi.org/10.17072/1995-4190-2020-50-678-704

5. Bogdanov, D. E. (2020a). The Impact of Bioprinting Technologies on the Development of Civil Liability. Lex Russica, 73(9), 88–99. (In Russ.). https://doi.org/10.17803/1729-5920.2020.166.9.088-099

6. Childress, J. F., Brister, E., Thompson, P. B., Wolf, S. M., Callier, S. L., Capron, A. M., Pruett, T. L., & Zuchowicz, N. (2024). Ethical Issues in Emerging Technologies to Extend the Viability of Biological Materials Across Time and Space. The Journal of Law, Medicine & Ethics: a Journal of the American Society of Law, Medicine & Ethics, 52(3), 570–584. https://doi.org/10.1017/jme.2024.139

7. Cossu, G., Birchall, M., Brown, T., De Coppi, P., Culme-Seymour, E., Gibbon, S., Hitchcock, J., Mason, C., Montgomery, J., Morris, S., Muntoni, F., Napier, D., Owji, N., Prasad, A., Round, J., Saprai, P., Stilgoe, J., Thrasher, A., & Wilson, J. (2018). Lancet Commission: Stem cells and regenerative medicine. The Lancet, 391(10123), 883–910. https://doi.org/10.1016/S0140-6736(17)31366-1

8. de Kanter, A. J., Jongsma, K. R., Verhaar, M. C., & Bredenoord, A. L. (2023). The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review. Tissue engineering. Part B: Reviews, 29(2), 167–187. https://doi.org/10.1089/ten.TEB.2022.0033

9. Dey, M., & Ozbolat, I. T. (2020). 3D bioprinting of cells, tissues and organs. Scientific Reports, 10, 14023. https://doi.org/10.1038/s41598-020-70086-y

10. Egorov, I. A., & Semenchuk, O. V. (2022). Application of 3D-printing technology in medicine. Chronos, 7(4), 29–32. (In Russ.). https://doi.org/10.52013/2658-7556-66-4-8

11. Galyukova, M. I. (2023). Background Causes for Criminal Liability for Bioprinting. Lex Russica, 76(1), 85–97. (In Russ.). https://doi.org/10.17803/1729-5920.2023.194.1.085-097

12. Gilbert, F., O'Connell, C. D., Mladenovska, T., & Dodds, S. (2018). Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine. Science and Engineering Ethics, 24(1), 73–91. https://doi.org/10.1007/s11948-017-9874-6

13. Girón Morazán, G. (2019). Las fronteras éticas de las aplicaciones biotecnológicas. Apuntes De Bioética, 2(1), 104-114. (In Spanish). https://doi.org/10.35383/apuntes.v2i1.246

14. Goddard, E., & Dodds, S. (2020). Ethics and Policy for Bioprinting. Methods in molecular biology (Clifton, N.J.), 2140, 43–64. https://doi.org/10.1007/978-1-0716-0520-2_4

15. Gulyaeva, P. S. (2023). Medical nanorobots in focus of law. Journal of Digital Technologies and Law, 1(1), 89–122. (In Russ.). https://doi.org/10.21202/jdtl.2023.4

16. Hesuani, Yu. D., Sergeeva, N. S., Mironov, V., Mustafin, A. G., & Kaprin, A. D. (2018). Introduction to 3D bioprinting: the history of the formation of the direction, principles and stages of bioprinting. Genes and Cells, 13(3), 38–45. https://doi.org/10.23868/201811031

17. Jovic, T. H., Combellack, E. J., Jessop, Z. M., & Whitaker, I. S. (2020). 3D Bioprinting and the Future of Surgery. Frontiers in Surgery, 7, 609836. https://doi.org/10.3389/fsurg.2020.609836

18. Kantaros, A., Ganetsos, Th., Petrescu, F. I. T., & Alysandratou, E. (2025). Bioprinting and Intellectual Property: Challenges, Opportunities, and the Road Ahead. Bioengineering, 12(1), 76. https://doi.org/10.3390/bioengineering12010076

19. Kaul, R. (2023). 13 – Social and ethical considerations of bioprinted organs. In D. M. Kalaskar (Eds.), 3D Printing in Medicine (2d Ed., pp. 379–384). Woodhead Publishing. https://doi.org/10.1016/B978-0-323-89831-7.00005-5

20. Khan, Z., & Siddique Dr, Afifa. (2022). 3D Bioprinting and Organ Transplantation: Patient Dream or Ethical Nightmare? Journal of Ethics and Emerging Technologies, 32(1), 1–9. https://doi.org/10.55613/jeet.v32i1.96

21. Kirillova, A., Bushev, S., Abubakirov, A., & Sukikh, G. (2020). Bioethical and Legal Issues in 3D Bioprinting. International Journal of Bioprinting, 6(3), 272. https://doi.org/doi:10.18063/ijb.v6i3.272

22. Kostenko, A., Connon, C. J., & Swioklo, S. (2022). Storable Cell-Laden Alginate Based Bioinks for 3D Biofabrication. Bioengineering, 10(1), 23. https://doi.org/10.3390/bioengineering10010023

23. Ksenofontova, D. S. (2020). Legal and Bioethical Changes in the Commodification of Human, Including Bioprinted, Organs and Tissues. Lex Russica, 73(9), 100–107. (In Russ.) https://doi.org/10.17803/1729-5920.2020.166.9.100-107

24. Kuszler, P. C. (2006). Biotechnology entrepreneurship and ethics: principles, paradigms, and products. Medicine and Law, 25(3), 491–502.

25. Li, P., & Faulkner, A. (2017). 3D Bioprinting Regulations: A UK/EU Perspective. European Journal of Risk Regulation, 8(2), 441–447. https://doi.org/10.1017/err.2017.19

26. Li, Ph. (2014). 3D Bioprinting Technologies: Patents, Innovation, and Access. Law, Innovation and Technology, 6(2), 282–304. https://doi.org/10.5235/17579961.6.2.282

27. Matai, I., Kaur, G., Seyedsalehi, A., McClinton, A., & Laurencin, C. T. (2020). Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials, 226, 119536. https://doi.org/10.1016/j.biomaterials.2019.119536

28. Melerzanov, A., Mishra, A., & Manturova, N. (2016). Three-dimensional bioprinting of organs: ethical and legislative aspects. Vrach, 5, 11–13. (In Russ.).

29. Shopova, D., Mihaylova, A., Kasnakova, P., Yaneva, A., Hristozova, M., Sbirkov, Y., Sarafian, V., Semerdjieva, M., & Bakova, D. (2022). (Bio)printing in modern medical education. ICERI2022 Proceedings (pp. 7157–7161). https://doi.org/10.21125/iceri.2022.1819

30. O'Mathúna, D. P. (2007). Bioethics and biotechnology. Cytotechnology, 53, 113–119. https://doi.org/10.1007/s10616-007-9053-8

31. Papaioannou, T. G., Manolesou, D., Dimakakos, E., Tsoucalas, G., Vavuranakis, M., & Tousoulis, D. (2019). 3D Bioprinting Methods and Techniques: Applications on Artificial Blood Vessel Fabrication. Acta Cardiologica Sinica, 35(3), 284–289.

32. Pashkov, V., & Harkusha, A. (2017). 3-D Bioprinting Law Regulation Perspectives. Wiadomości Lekarskie, 70(3), 480–482.

33. Patuzzo, S., Goracci, G., Gasperini, L. et al. (2018). 3D Bioprinting Technology: Scientific Aspects and Ethical Issues. Science and Engineering Ethics, 24, 335–348. https://doi.org/10.1007/s11948-017-9918-y

34. Polyanskaya, A. A., Gurkina, D. B., Sterleva, E. A., Kuznetsova, O. V., & Sergeev, Yu. A. (2022). Bioprinting in medicine. Features and prospects of use. International Journal of Applied Sciences and Technologies “Integral”, 1. (In Russ.).

35. Prikhodko, A. A., Vinogradov, R. A., & Vakhrushev, S. G. (2019). Measures for the Development of Medical Additive Technologies in the Russian Federation. Medical Technologies. Assessment and Choice, 2(36), 10–15. (In Russ.). https://doi.org/10.31556/2219-0678.2019.36.2.010-015

36. Ricci, G., Gibelli, F., & Sirignano, A. (2023). Three-Dimensional Bioprinting of Human Organs and Tissues: Bioethical and Medico-Legal Implications Examined through a Scoping Review. Bioengineering, 10(9), 1052. https://doi.org/10.3390/bioengineering10091052

37. Rizzo, M. L., Turco, S., Spina, F., Costantino, A., Visi, G., Baronti, A., Maiese, A., & Di Paolo, M. (2023). 3D printing and 3D bioprinting technology in medicine: ethical and legal issues. La Clinica Terapeutica, 174(1), 80–84. https://doi.org/10.7417/CT.2023.2501

38. Romanovskaya, O. V., & Romanovskiy, G. B. (2023). Legal regulation of additive technologies in modern biomedicine. RUDN Journal of Law, 27(1), 21–40. (In Russ.). https://doi.org/10.22363/2313-2337-2023-27-1-21-40

39. Salvaterra, E. (2023). Human Fabrication: An Ethical Viewpoint. Stem Cell & Regenerative Medicine, 7(2), 1–2.

40. Shutova, A. A., & Begishev, I. R. (2023). Project of an Ethical Code of subjects implementing activity of creating, applying and utilizing medical products based on bioprinting technologies, interacting with patients and cell donors, turnover of donor cells, bioink and bioprint tissue (organ) constructs. Legal and Order: History, Theory, Practice, 4(39), 239–247. (In Russ.). https://doi.org/10.47475/2311-696X-2023-39-4-239-247

41. Taylor, D. A., Caplan, A. L., & Macchiarini, P. (2014). Ethics of bioengineering organs and tissues. Expert Opinion on Biological Therapy, 14(7), 879–882. https://doi.org/10.1517/14712598.2014.915308

42. Utegen, D., & Rakhmetov, B. Zh. (2023). Facial Recognition Technology and Ensuring Security of Biometric Data: Comparative Analysis of Legal Regulation Models. Journal of Digital Technologies and Law, 1(3), 825–844. (In Russ.). https://doi.org/10.21202/jdtl.2023.36.

43. Veeravalli, R. S., Vejandla, B., Savani, S., Nelluri, A., & Peddi, N. C. (2023). Three-Dimensional Bioprinting in Medicine: A Comprehensive Overview of Current Progress and Challenges Faced. Cureus, 15(7), e41624. https://doi.org/10.7759/cureus.41624

44. Vermeulen, N., Haddow, G., Seymour, T., Faulkner-Jones, A., & Shu, W. (2017). 3D bioprint me: a socioethical view of bioprinting human organs and tissues. Journal of Medical Ethics, 43(9), 618–624. https://doi.org/10.1136/medethics-2015-103347

45. Vijayavenkataraman, S., Lu, W. F., & Fuh, J. Y. H. (2016). 3D bioprinting – An Ethical, Legal and Social Aspects (ELSA) framework. Bioprinting, 1–2, 11–21. https://doi.org/https://doi.org/10.1016/j.bprint.2016.08.001